Sort Results:
List of Materials
 |
Pharmaceutical Impurity Analysis SolutionsPrimer: 1. PHARMACEUTICAL IMPURITY ANALYSIS OVERVIEW AND REGULATORY SITUATION 2. ANALYTICAL TECHNOLOGIES FOR IMPURITY PROFILING IN PHARMACEUTICAL DEVELOPMENT 3. A SELECTION OF AGILENT APPLICATION SOLUTIONS FOR THE THREE MAJOR TYPES OF IMPURITIES |
Agilent Technologies Presenter: Agilent Technologies |
|
Recombinant Protein Characterization Primer1. Introduction to recombinant proteins 2. Biologic Process Monitoring 3. Intact Protein Identity, Purity, and Impurities 4. Glycan Analysis and Profi ling 5. Peptide Mapping 6. Charge Isoforms 7. ... |
Agilent Technologies Presenter: Agilent Technologies |
|
Risk, Issue and Opportunity in Drug DeveopmentHolistic risk, issue and opportunity management in drug development requires close coordination and alignment of approaches, strategies and tools across the whole program among all participating stakeholders to account for technical, business and... |
ARETE-ZOE, LLC Presenter: Veronika Valdova |
|
The LC Handbook: Guide to LC Columns and Method DevelopmentGuide to LC Columns and Method Development |
Agilent Technologies Presenter: Agilent Technologies |
|
The Small Molecule Discovery CenterThis presentation introduces the Small Molecule Discovery Center at UCSF, and describes the center’s goals, philosophy, and examples of projects. Several different approaches to interacting with pharmaceutical companies are also summarized. |
Small Molecule Discovery Center University of California San Francisco Presenter: Michelle Arkin |
|
Vanderbilt Center for Neuroscience Drug Discovery: Translating Basic Science into Patient CareLearn more about the Vanderbilt Center for Neuroscience Drug Discovery at Vanderbilt University. This presentation discusses the Center's mission, its infrastructure, program areas and projects.' |
Vanderbilt Center for Neuroscience Drug Discovery Vanderbilt University Presenter: P. Jeffrey Conn |